Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China flag China · Delayed Price · Currency is CNY
25.30
-0.74 (-2.84%)
Sep 9, 2026, 4:00 PM EDT

SHA:603207 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
537.42525.28474.58471.87456.89401.77
Revenue Growth
11.36%10.68%0.57%3.28%13.72%11.22%
Gross Profit
328.63341.25311.3308.8269.45254.43
Operating Income
219.81238.19233.49230.48195.85142.84
Net Income
192.22207.49205.27203.63175.18126.27
Earnings Per Share
1.201.291.531.701.461.05
EPS Growth
-10.48%-15.69%-10.00%16.44%39.05%-

Revenue by Geography

Fiscal YearFY 2025
Period EndingDec '25
East China
182.77
North China
69.59
South China
85.52
Southwest
59.12
Central China
58.87
Northeast
45.23
Northwest
23.4
Overseas
0.21
Total
524.7

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
674.68647.59883.43288.52168.93208.01
Total Debt
9.492.52.320.860.881.27
Net Cash (Debt)
665.2645.08881.11287.65168.05206.74
Net Cash Growth
-5.82%-26.79%206.31%71.17%-18.71%83.45%
Net Cash Per Share
4.154.016.572.401.401.72

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
168.27160.8212.21200.26137.2179.51
Capital Expenditures
-84.9-54.24-83.94-80.15-61.59-12.48
Free Cash Flow
83.37106.56128.27120.1175.61167.03
Free Cash Flow Growth
-34.11%-16.93%6.79%58.86%-54.73%20.59%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.15%64.96%65.59%65.44%58.97%63.33%
Operating Margin
40.90%45.35%49.20%48.84%42.86%35.55%
Pretax Margin
41.55%45.92%50.47%50.26%45.10%38.47%
Profit Margin
35.77%39.50%43.25%43.15%38.34%31.43%
FCF Margin
15.51%20.29%27.03%25.45%16.55%41.57%

Dividends

Fiscal YearCurrentFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Dividend Per Share
1.0701.0701.500
Dividend Per Share Growth
0%-28.67%-
Dividend Yield
3.83%3.80%5.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.0922.1521.90---
P/FCF Ratio
48.7643.1335.04---
PS Ratio
7.568.759.47---